Oral Nanoarmored Lactobacillus rhamnosus with Inflammation Targeting and Scavenging Activities for Colitis Lesion-Specific Therapy
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.6c00800 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Wen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Province Key Laboratory of Biomedical Materials and Chemical Measurement,…. Hauptthemen laut MEDLINE: Lacticaseibacillus rhamnosus, Colitis, Probiotics, Nanoparticles. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
Nanoarmored probiotics with inflammation targeting and scavenging activities without complex synthetic procedure is important for maintaining their native bioactivity, yet it remains a challenge. In this work, we demonstrated the multifunctional nanoparticle (QL@PS NP)-armored Lactobacillus rhamnosus (LAB) with inflammation targeting and regulation activity for inflammatory bowel disease (IBD) treatment. QL@PS NPs were assembled by quercetin (Que), lipoic acid (LA), and phosphatidylserine (PS), which could target macrophages and degrade in reactive oxygen species (ROS)-rich lesion sites, exhibiting excellent antioxidant and anti-inflammatory capability in vitro. QL@PS NPs were coated on the surface of thiolated LAB under a cell-friendly condition, and the resulting nanoarmored probiotic (LAB@NPs) could protect LAB from the gastrointestinal assaults and ROS damage. LAB@NPs are more likely to be up-taken by macrophages, scavenging oxidative stress and regulating the inflammatory microenvironment of colitis lesions through the synergistic effect of probiotics and QL@PS NPs. In vivo experimental results certified that LAB@NPs achieved notable lesion-specific therapeutic efficacy in mouse colitis models, significantly ameliorating colon shortening, reducing inflammatory reactions and pathological tissue damage. This work provides a facile and effective strategy to construct nanoarmored probiotics for therapy of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Province Key Laboratory of Biomedical Materials and Chemical Measurement, College of Chemistry and Molecular Science, Anhui Normal University,…
ORCID-Profile: Xiaomei Dai, Feng Gao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Higher Education Discipline Innovation Project
Zitieren
APA
Li, W., Yuan, S., Wu, H., Huang, M., Yang, X., Zou, Y., Dai, X., & Gao, F. (2026). Oral Nanoarmored Lactobacillus rhamnosus with Inflammation Targeting and Scavenging Activities for Colitis Lesion-Specific Therapy. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.6c00800
Vancouver
Li W, Yuan S, Wu H, Huang M, Yang X, Zou Y, et al. Oral Nanoarmored Lactobacillus rhamnosus with Inflammation Targeting and Scavenging Activities for Colitis Lesion-Specific Therapy. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.6c00800
BibTeX
@article{Li2026,
author = {Li, Wen and Yuan, Siyuan and Wu, Hongjing and Huang, Menglin and Yang, Xue and Zou, Yuqin and Dai, Xiaomei and Gao, Feng},
title = {Oral Nanoarmored Lactobacillus rhamnosus with Inflammation Targeting and Scavenging Activities for Colitis Lesion-Specific Therapy},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.6c00800}
}
EUVIMED